Overview

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ciudad Universitaria, Spain
Treatments:
Alendronate
Criteria
Inclusion Criteria:

- postmenopausal osteoporosis under densitometric criteria of the World Health
Organization

Exclusion Criteria:

- secondary osteoporosis

- alteration in analytic parameters (total proteins, calcium, phosphorus, vitamin D,
parathyroid hormone, thyroid hormone, transaminase, creatinine)